Radiopharm Theranostics Files March 2025 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, reporting
TL;DR
Radiopharm Theranostics filed its March 6-K, confirming 20-F annual report filing and Australian HQ.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on March 13, 2025, reporting information for the month of March 2025. The company is a foreign private issuer and will file its annual reports under Form 20-F. Its principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Why It Matters
This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- March 2025 (date) — Reporting period
- Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (location) — Principal executive office
- Form 20-F (document) — Annual report filing type
- Form 6-K (document) — Filing type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC when they make public certain information that they have made or are required to make public in their home country.
Which annual report form will Radiopharm Theranostics Limited file?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
Where is Radiopharm Theranostics Limited's principal executive office located?
The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the SEC file number for Radiopharm Theranostics Limited?
The SEC file number for Radiopharm Theranostics Limited is 001-41621.
Does Radiopharm Theranostics Limited furnish information under Rule 12g3-2(b)?
No, Radiopharm Theranostics Limited has indicated that it is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).